Cargando…

The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis

OBJECTIVE: Cotrimoxazole prevents opportunistic infections including falciparum malaria in HIV-infected individuals but there are concerns of cross-resistance to other antifolate drugs such as sulphadoxine-pyrimethamine (SP). In this study, we investigated the prevalence of antifolate-resistance mut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Juma, Dennis W., Muiruri, Peninah, Yuhas, Krista, John-Stewart, Grace, Ottichilo, Ronald, Waitumbi, John, Singa, Benson, Polyak, Christina, Kamau, Edwin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445470/ https://www.ncbi.nlm.nih.gov/pubmed/30897090 http://dx.doi.org/10.1371/journal.pntd.0007223

Ejemplares similares

Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial
por: Polyak, Christina S., et al.
Publicado: (2016)

Genetically Determined Response to Artemisinin Treatment in Western Kenyan Plasmodium falciparum Parasites
por: Chebon, Lorna J., et al.
Publicado: (2016)

Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan
por: Awab, Ghulam R, et al.
Publicado: (2013)

Antifolate Agents Against Wild and Mutant Strains of Plasmodium falciparum
por: Shaikh, M. S., et al.
Publicado: (2014)

Independent Origin of Plasmodium falciparum Antifolate Super-Resistance, Uganda, Tanzania, and Ethiopia
por: Alifrangis, Michael, et al.
Publicado: (2014)

Submicroscopic Gametocytes and the Transmission of Antifolate-Resistant Plasmodium falciparum in Western Kenya
por: Oesterholt, Mayke J. A. M., et al.
Publicado: (2009)

Selective sweeps and genetic lineages of Plasmodium falciparum multi-drug resistance (pfmdr1) gene in Kenya
por: Muiruri, Peninah, et al.
Publicado: (2018)

Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether–lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya
por: Achieng, Angela O., et al.
Publicado: (2015)

Escalating Plasmodium falciparum antifolate drug resistance mutations in Macha, rural Zambia
por: Mkulama, Mtawa AP, et al.
Publicado: (2008)

Molecular markers of antifolate resistance in Plasmodium falciparum isolates from Luanda, Angola
por: Gama, Bianca E, et al.
Publicado: (2011)

Tracing the origins and signatures of selection of antifolate resistance in island populations of Plasmodium falciparum
por: Salgueiro, Patrícia, et al.
Publicado: (2010)

Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016
por: Sugaram, Rungniran, et al.
Publicado: (2020)

A Genetically Hard-Wired Metabolic Transcriptome in Plasmodium falciparum Fails to Mount Protective Responses to Lethal Antifolates
por: Ganesan, Karthikeyan, et al.
Publicado: (2008)

Delayed acquisition of Plasmodium falciparum antigen-specific CD4(+) T cell responses in HIV-exposed uninfected Malawian children receiving daily cotrimoxazole prophylaxis
por: Longwe, Herbert, et al.
Publicado: (2016)

Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design
por: Anywaine, Zacchaeus, et al.
Publicado: (2015)

Increased malaria parasitaemia among adults living with HIV who have discontinued cotrimoxazole prophylaxis in Kitgum district, Uganda
por: Orishaba, Philip, et al.
Publicado: (2020)

Apoptosis stalks Plasmodium falciparum maintained in continuous culture condition
por: Mutai, Beth K, et al.
Publicado: (2010)

Molecular surveillance of putative drug resistance markers of antifolate and artemisinin among imported Plasmodium falciparum in Qatar
por: Bansal, Devendra, et al.
Publicado: (2019)

Complement Activation by Merozoite Antigens of Plasmodium falciparum
por: Korir, Jackson C., et al.
Publicado: (2014)

Complement consumption in children with Plasmodium falciparum malaria
por: Nyakoe, Nancy K, et al.
Publicado: (2009)

Characterisation of the bifunctional dihydrofolate synthase–folylpolyglutamate synthase from Plasmodium falciparum; a potential novel target for antimalarial antifolate inhibition
por: Wang, Ping, et al.
Publicado: (2010)

Prevalence of chloroquine and antifolate drug resistance alleles in Plasmodium falciparum clinical isolates from three areas in Ghana
por: Abugri, James, et al.
Publicado: (2018)

Genetic polymorphism of merozoite surface protein 1 and antifolate-resistant genes in Plasmodium falciparum from Mali and Niger
por: Lamine, Mahaman Moustapha, et al.
Publicado: (2023)

Cotrimoxazole Prophylaxis and Tuberculosis Risk among People Living with HIV
por: Hoffmann, Christopher J., et al.
Publicado: (2014)

Cotrimoxazole prophylaxis and antiretroviral therapy: an observational cohort study in China
por: Cheng, Wei, et al.
Publicado: (2015)

National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and Links
por: Hutchinson, Eleanor, et al.
Publicado: (2011)

Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV
por: Ku, Stephane Wen‐Wei, et al.
Publicado: (2019)

Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries
por: Srisutham, Suttipat, et al.
Publicado: (2022)

Cotrimoxazole Prophylaxis Specifically Selects for Cotrimoxazole Resistance in Streptococcus mutans and Streptococcus sobrinus with Varied Polymorphisms in the Target Genes folA and folP
por: William, Buwembo, et al.
Publicado: (2012)

Linking HIV-Infected TB Patients to Cotrimoxazole Prophylaxis and Antiretroviral Treatment in India
por: Raizada, Neeraj, et al.
Publicado: (2009)

Factors Associated with Coverage of Cotrimoxazole Prophylaxis in HIV-Exposed Children in South Africa
por: Moodley, Dhayendre, et al.
Publicado: (2013)

The Impact of Short-Term, Intensive Antifolate Treatment (with Pyrimethamine and Sulfadoxine) and Antibiotics Followed by Long-Term, Secondary Antifolate Prophylaxis on the Rate of Toxoplasmic Retinochoroiditis Recurrence
por: Borkowski, Piotr K., et al.
Publicado: (2016)

Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012
por: Juma, Dennis W, et al.
Publicado: (2014)

Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017
por: Rakmark, Kasama, et al.
Publicado: (2020)

Plasmodium falciparum Histidine-Rich Protein 2 and 3 Gene Deletions and Their Implications in Malaria Control
por: Nyataya, Josphat, et al.
Publicado: (2020)

Impact of Plasmodium falciparum infection on haematological parameters in children living in Western Kenya
por: Maina, Robert N, et al.
Publicado: (2010)

Cotrimoxazole Prophylaxis and Risk of Severe Anemia or Severe Neutropenia in HAART-Exposed, HIV-Uninfected Infants
por: Dryden-Peterson, Scott, et al.
Publicado: (2013)

Prevalence and patterns of antifolate and chloroquine drug resistance markers in Plasmodium vivax across Pakistan
por: Khattak, Aamer A, et al.
Publicado: (2013)

Molecular surveillance of the antifolate-resistant mutation I164L in imported african isolates of Plasmodium falciparum in Europe: sentinel data from TropNetEurop
por: Wichmann, Ole, et al.
Publicado: (2003)

Impact of Anti-Retroviral Treatment and Cotrimoxazole Prophylaxis on Helminth Infections in HIV-Infected Patients in Lambaréné, Gabon
por: Janssen, Saskia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rmf4ira6m98celnapaccn466h0